![Peter McNamara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter McNamara
Geen lopende functies
Vermogen: 2 M $ op 30-06-2026
Profiel
Dr. Peter McNamara is a Chief Scientific Officer at Tectonic Therapeutic, Inc. Dr. McNamara was previously employed as a Chief Scientific Officer by AVROBIO, Inc., an Executive Director-Biotherapeutics & Biotechnology by Novartis Institute for Functional Genomics, Inc., and a Director-Pharmacology by Phenomix Corp.
He received his undergraduate degree from National University of Ireland Galway and a doctorate degree from National University of Ireland Galway.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,29% | 30-06-2026 | 55.285 ( 0,29% ) | 2 M $ | 30-06-2026 |
Actieve functies van Peter McNamara
| Bedrijven | Functie | Begin |
|---|
Eerdere bekende functies van Peter McNamara
| Bedrijven | Functie | Einde |
|---|---|---|
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Corporate Officer/Principal | 01-04-2021 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 01-08-2005 |
| TECTONIC THERAPEUTIC, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Peter McNamara
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
16
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
National University of Ireland Galway
 National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
